跳至主要内容
临床试验/NL-OMON55769
NL-OMON55769已完成不适用

Anti-reflux mucosectomy for gastroesophageal reflux disease: efficacy and mechanism of action. - ARMS-trial

Academisch Medisch Centrum0 个研究点目标入组 11 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Gastroesophageal reflux disease confirmed by a 24-h ambulatory pH-impedance
  • study (symptom association probability *95%; esophageal acid exposure *4%)
  • - Symptoms of heartburn, regurgitation and/or chest pain under PPI-treatment
  • for at least 3 months at least 3 times a week.
  • - Use of proton pump inhibitors at a standard dose twice a day for at least 4
  • weeks prior to inclusion.

排除标准

  • - ASA classification of III or higher.
  • - Previous (surgical or endoscopic) anti-reflux procedure
  • - Previous surgery of the stomach or esophagus
  • - Sliding hiatal hernia >2cm
  • - Esophagitis grade C or D
  • - Presence of Barrett*s esophagus with dysplasia
  • - Known coagulopathy
  • - Unable to stop coagulants (with the exception of mono antiplatelet therapy)
  • - Presence of liver cirrhosis and/or esophageal varices
  • - Presence of a stricture of the esophagus
  • - Presence of eosinophilic esophagitis
  • - Presence of achalasia
  • - Presence of connective tissue disorder
  • - Absent peristalsis on high-resolution manometry
  • - Pregnancy at time of treatment

研究者

相似试验